Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | (S)-(+)-N-3-Benzylnirvanol REF: TM-T67926CAS: 790676-40-3 | 98.76% | 144.00 €~1,501.00 € | Thu 27 Mar 25 |
![]() | (+)-N-3-Benzylnirvanol REF: 7W-GL2703CAS: 790676-40-3 | (HPLC) ≥ 98.0% | To inquire | Thu 27 Mar 25 |
![]() | (S)-(+)-N-3-Benzylnirvanol REF: TR-B285775CAS: 790676-40-3 | - - - | 351.00 €~2,341.00 € | Mon 07 Apr 25 |
![]() | (S)-(+)-N-3-Benzylnirvanol REF: 3D-FB172452CAS: 790676-40-3 | Min. 95% | - - - | Discontinued product |

(S)-(+)-N-3-Benzylnirvanol
CAS:790676-40-3
(S)-(+)-N-3-Benzylnirvanol is a cytochrome P450 CYP2C19 inhibitor with a ki value of 82.5μM for CYP2C9 …
Formula:
C18H18N2O2
Purity:
98.76%
Color and Shape:
Soild
Molecular weight:
294.35
Ref: TM-T67926
1mg | 144.00 € | ||
5mg | 359.00 € | ||
10mg | 532.00 € | ||
25mg | 838.00 € | ||
50mg | 1,130.00 € | ||
100mg | 1,501.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025

(+)-N-3-Benzylnirvanol
CAS:790676-40-3
Formula:
C18H18N2O2
Purity:
(HPLC) ≥ 98.0%
Color and Shape:
White to off-white powder
Molecular weight:
294.35
Ref: 7W-GL2703
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 27 Mar 2025

(S)-(+)-N-3-Benzylnirvanol
Controlled ProductCAS:790676-40-3
Applications It is a potent and selective human CYP2C19 inhibitor. Not a dangerous good if …
Formula:
C18H18N2O2
Color and Shape:
White To Off-White
Molecular weight:
294.35
Ref: TR-B285775
5mg | 351.00 € | ||
10mg | 680.00 € | ||
50mg | 2,341.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025

(S)-(+)-N-3-Benzylnirvanol
CAS:790676-40-3
Please enquire for more information about (S)-(+)-N-3-Benzylnirvanol including the price, delivery time and more detailed …
Formula:
C18H18N2O2
Purity:
Min. 95%
Molecular weight:
294.35 g/mol
Ref: 3D-FB172452
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |